BOSTON, United States and LAUSANNE, Switzerland – November 2, 2022 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, debuted new data at the European Society ...
WATERTOWN, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company discovering and developing ...
Dr Kathleen Moore from the University of Oklahoma Health Sciences Center reviews key ovarian cancer abstracts from ESGO 2025. She first highlights a multicenter study comparing three vs six cycles of ...
YANTAI, China, March 10, 2024 /PRNewswire/ -- RemeGen Co. Ltd.("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently gave an oral presentation on an ...
Recommended dose of 7 MBq established following completion of dose escalation; no dose-limiting toxicity observed OSLO, Norway--(BUSINESS WIRE)--Oncoinvent AS, a clinical stage company advancing alpha ...
Over the past 12 months, ESGO has changed by 162.79%, with its 52-week range spanning from 8.17 to 24.77. What Is the Daily Trading Range for ESGO? The daily trading range for ESGO has fluctuated ...
Live webcast of event on February 27 at 8:00 a.m. ET will include participation of globally renowned gynecological oncology KOLs from the US and EU KOL panel to discuss maturing data from the ACR-368 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results